v3.25.2
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Available-for-Sale, Amortized Cost $ 336,206 $ 376,265
Financing Receivable, Allowance for Credit Loss [1] $ 18,345 $ 20,449
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 75,000,000 75,000,000
Common stock, shares issued (in shares) 9,444,963 9,353,348
Common stock, shares outstanding (in shares) 9,444,963 9,353,348
[1] Allowance for credit losses on loans in 2023 reported using the CECL method and in 2022 reported using the incurred loss method.